AC009133.22 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000404873} | Predicted secreted proteins
| ![](/images/11887/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/11887/29435_B_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
AFAP1L2 | Actin filament associated protein 1-like 2 | Predicted intracellular proteins
| ![](/images/37843/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/37843/76927_B_5_6_rna_selected_60x60.jpg) | Tissue enhanced |
AIM2 | Absent in melanoma 2 | Predicted intracellular proteins
| ![](/images/31365/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/31365/67667_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
APOBEC3A | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | Predicted intracellular proteins
| ![](/images/43237/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/43237/93176_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | ![](/images/3595/if_selected_60x60.jpg) | ![](/images/3595/ihc_cell_selected_60x60.jpg) | ![](/images/3595/11122_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ARHGAP25 | Rho GTPase activating protein 25 | Plasma proteins Predicted intracellular proteins
| | ![](/images/61395/1419_G8_3_selected_60x60.jpg) | ![](/images/35346/147080_A_9_11_selected_60x60.jpg) | ![](/images/35346/70558_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
AURKB | Aurora kinase B | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| ![](/images/5862/ihc_selected_60x60.jpg) | | ![](/images/5862/ihc_cell_selected_60x60.jpg) | ![](/images/5862/15412_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
BATF | Basic leucine zipper transcription factor, ATF-like | Predicted intracellular proteins Transcription factors
| ![](/images/64962/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/64962/152378_A_1_1_rna_selected_60x60.jpg) | Tissue enhanced |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | ![](/images/49117/1363_F2_2_selected_60x60.jpg) | | ![](/images/49117/110535_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
BIN2 | Bridging integrator 2 | Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/38667/106333_A_3_5_rna_selected_60x60.jpg) | Tissue enhanced |
BRCA2 | Breast cancer 2, early onset | Cancer-related genes Disease related genes Predicted intracellular proteins
| ![](/images/26815/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/26815/59972_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | ![](/images/1198/2772_A_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
C12orf77 | Chromosome 12 open reading frame 77 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/68791/155286_A_3_7_rna_selected_60x60.jpg) | Tissue enhanced |
C17orf53 | Chromosome 17 open reading frame 53 | Predicted intracellular proteins
| | | ![](/images/23004/ihc_cell_selected_60x60.jpg) | ![](/images/24430/54189_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
C5AR1 | Complement component 5a receptor 1 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/2720/ihc_selected_60x60.jpg) | | ![](/images/14520/ihc_cell_selected_60x60.jpg) | ![](/images/2720/6690_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CCL21 | Chemokine (C-C motif) ligand 21 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5067/13768_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
CCNDBP1 | Cyclin D-type binding-protein 1 | Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/20664/46918_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CCNE1 | Cyclin E1 | Cancer-related genes Predicted intracellular proteins
| ![](/images/18169/43894_A_6_6_selected_60x60.jpg) | | ![](/images/16682/ihc_cell_selected_60x60.jpg) | ![](/images/18169/43893_A_2_4_rna_selected_60x60.jpg) | Tissue enhanced |
CCNE2 | Cyclin E2 | Cancer-related genes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19374/44163_A_6_7_rna_selected_60x60.jpg) | Tissue enhanced |
CCR6 | Chemokine (C-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14488/33886_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
CCRN4L | CCR4 carbon catabolite repression 4-like (S. cerevisiae) | Enzymes Predicted intracellular proteins
| ![](/images/12287/ihc_selected_60x60.jpg) | | ![](/images/12287/35312_A_3_5_selected_60x60.jpg) | ![](/images/12287/32154_B_3_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD163L1 | CD163 molecule-like 1 | CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/15663/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/15663/34961_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CD180 | CD180 molecule | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3740/11072_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/3883/11412_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CD22 | CD22 molecule | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/24353/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2418/6099_A_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD226 | CD226 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15715/37859_A_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD247 | CD247 molecule | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/8750/27531_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2420/6095_A_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD300LF | CD300 molecule-like family member f | CD markers Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13712/117004_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
CD37 | CD37 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2492/6131_A_2_6_rna_selected_60x60.jpg) | Tissue enhanced |
CD3D | CD3d molecule, delta (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13055/32209_A_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/43955/119468_A_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CD3G | CD3g molecule, gamma (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17520/39922_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
CD40LG | CD40 ligand | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins
| | ![](/images/45827/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/45827/105628_A_2_2_rna_selected_60x60.jpg) | Tissue enhanced |
CD48 | CD48 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2497/6307_A_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CD5 | CD5 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images/20308/if_selected_60x60.jpg) | | ![](/images/15392/34316_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
CD6 | CD6 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images/2489/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2489/6143_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
CD69 | CD69 molecule | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2503/6465_A_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD7 | CD7 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/39079/134055_A_2_5_selected_60x60.jpg) | ![](/images/2594/6570_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
CD79A | CD79a molecule, immunoglobulin-associated alpha | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/19/395_A_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| ![](/images/9178/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/9178/26322_A_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD80 | CD80 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25368/56075_B_1_8_rna_selected_60x60.jpg) | Tissue enhanced |
CD83 | CD83 molecule | CD markers Predicted membrane proteins
| | ![](/images/41454/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2509/6584_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
CD84 | CD84 molecule | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/70502/156477_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD8A | CD8a molecule | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/37756/ihc_cell_selected_60x60.jpg) | ![](/images/12/106_B_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD8B | CD8b molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4353/13280_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
CDCA4 | Cell division cycle associated 4 | Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/59416/132691_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CDCA5 | Cell division cycle associated 5 | Predicted intracellular proteins
| ![](/images/23691/ihc_selected_60x60.jpg) | | ![](/images/23691/ihc_cell_selected_60x60.jpg) | ![](/images/23691/51600_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
CDH4 | Cadherin 4, type 1, R-cadherin (retinal) | Predicted membrane proteins
| ![](/images/15613/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/15613/35995_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
CENPU | Centromere protein U | Predicted intracellular proteins
| ![](/images/22048/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/22048/55314_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |